Aclerastide clinical trials
Also written DSC127.
How each study uses aclerastide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2013 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
US Biotest, Inc. (2) · Integra LifeSciences Corporation (2)
Studies
Open first, then newest update. How each study uses aclerastide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study of the Safety of USB005 in Healthy VolunteersCompletedPhase 1US Biotest, Inc.NCT03615196Written as USB005 (aclerastide) Ophthalmic Solution
- Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot UlcersTerminatedPhase 3Integra LifeSciences CorporationNCT01830348Written as DSC127
- Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot UlcersTerminatedPhase 3Integra LifeSciences CorporationNCT01849965Written as DSC127
- Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic UlcersCompletedPhase 2US Biotest, Inc.NCT00796744Written as NorLeu3-A(1-7) in a gel formulation
Codes
What other systems call aclerastide · ClinicalTrials.gg INT001021
- MeSH (NLM) C000629415aclerastideOne source NLM
- UNII (FDA) YYD6UT8T47ACLERASTIDEConfirmed FDA, NLM
- NCI Thesaurus C169759AclerastideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629415 | aclerastide | One source NLM |
| UNII (FDA) | YYD6UT8T47 | ACLERASTIDE | Confirmed FDA, NLM |
| NCI Thesaurus | C169759 | Aclerastide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.